Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24129863 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irina Tolmacheva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Perm Federal Scientific Centre, Institute of Technical Chemistry UB RAS, Academician Korolev St. 3, 614013 Perm, Russia. Hauptthemen laut MEDLINE: Doxorubicin, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Multidrug resistance (MDR) is a common phenomenon in clinical oncology, whereby cancer cells become resistant to chemotherapeutic drugs. A common MDR mechanism is the overexpression of ATP-binding cassette efflux transporters in cancer cells, with P-glycoprotein (P-gp) being one of them. New 3,4-seco-lupane triterpenoids, and the products of their intramolecular cyclization with the removed 4,4-gem-dimethyl group, were synthesized by the selective transformations of the A-ring of dihydrobetulin. Among the semi-synthetic derivatives, the MT-assay-enabled methyl ketone 31 (MK), exhibiting the highest cytotoxicity (0.7–16.6 µM) against nine human cancer cell lines, including P-gp overexpressing subclone HBL-100/Dox, is identified. In silico, MK has been classified as a potential P-gp-inhibitor; however, the Rhodamine 123 efflux test, and the combined use of P-gp-inhibitor verapamil with MK in vitro, showed the latter to be neither an inhibitor nor a substrate of P-gp. As the studies have shown, the cytotoxic effect of MK against HBL-100/Dox cells is, arguably, induced through the activation of the ROS-mediated mitochondrial pathway, as evidenced by the positive Annexin V-FITC staining of apoptotic cells, the cell cycle arrest in the G0/G1 phase, mitochondrial dysfunction, cytochrome c release, and the activation of caspase-9 and -3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perm Federal Scientific Centre, Institute of Technical Chemistry UB RAS, Academician Korolev St. 3, 614013 Perm, Russia.
ORCID-Profile: Yulia Beloglazova, Olga Gagarskikh, Victoria Grishko
Förderung
- Russian Science Foundation
Zitieren
APA
Tolmacheva, I., Beloglazova, Y., Nazarov, M., Gagarskikh, O., & Grishko, V. (2023). Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129863
Vancouver
Tolmacheva I, Beloglazova Y, Nazarov M, Gagarskikh O, Grishko V. Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129863
BibTeX
@article{Tolmacheva2023,
author = {Tolmacheva, Irina and Beloglazova, Yulia and Nazarov, Mikhail and Gagarskikh, Olga and Grishko, Victoria},
title = {Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24129863}
}
EUVIMED